APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy Development and Manufacturing Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cell Therapy Development and Manufacturing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 April 2026198 pages

Choose your research edition.

Industry ResearchCell Therapy Development and Manufacturing Services Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy Development and Manufacturing Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Cell Therapy Development and Manufacturing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy Development and Manufacturing Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Cell Therapy Development and Manufacturing Services Market Analysis and Forecast 2026-2032238 pages · $4,950 USD

Market perspective

The global Cell Therapy Development and Manufacturing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cell Therapy Development and Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell Therapy Development and Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Therapy Development and Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cell Therapy Development and Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cell Therapy Development and Manufacturing Services include AGC Biologics, AmplifyBio, Charles River Laboratories, Thermo Fisher Scientific, FUJIFILM Cellular Dynamics, Wuxi AppTec, KBI Biopharma, Lonza and Catalent Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cell Therapy Development and Manufacturing Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Therapy Development and Manufacturing Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Therapy Development and Manufacturing Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell Therapy Development and Manufacturing Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell Therapy Development and Manufacturing Services Segment by Company

AGC Biologics

AmplifyBio

Charles River Laboratories

Thermo Fisher Scientific

FUJIFILM Cellular Dynamics

Wuxi AppTec

KBI Biopharma

Lonza

Catalent Biologics

Oxford BioMedica

GenScript

Cell-Easy

SK pharmteco

RoslinCT

Cell and Gene Therapy Catapult

Cell Therapies

Minaris Regenerative Medicine

MEDINET

Cell Therapy Development and Manufacturing Services Segment by Type

Stem Cell Therapy

Somatic Cell Therapy

Cell Therapy Development and Manufacturing Services Segment by Application

Pharmaceutical Company

Research Institute

Cell Therapy Development and Manufacturing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy Development and Manufacturing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy Development and Manufacturing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy Development and Manufacturing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell Therapy Development and Manufacturing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Therapy Development and Manufacturing Services industry.

Chapter 3: Detailed analysis of Cell Therapy Development and Manufacturing Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy Development and Manufacturing Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Therapy Development and Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Stem Cell Therapy Table 3. Key Players of Somatic Cell Therapy Table 4. Global Cell Therapy Development and Manufacturing Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Company Table 6. Key Players of Research Institute Table 7. Global Cell Therapy Development and Manufacturing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Cell Therapy Development and Manufacturing Services Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Cell Therapy Development and Manufacturing Services Market Share by Region (2021-2026) Table 10. Global Cell Therapy Development and Manufacturing Services Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Cell Therapy Development and Manufacturing Services Market Share by Region (2027-2032) Table 12. Cell Therapy Development and Manufacturing Services Industry Trends Table 13. Cell Therapy Development and Manufacturing Services Industry Drivers Table 14. Cell Therapy Development and Manufacturing Services Industry Opportunities and Challenges Table 15. Cell Therapy Development and Manufacturing Services Industry Restraints Table 16. Global Cell Therapy Development and Manufacturing Services Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Company (2021-2026) Table 18. Global Cell Therapy Development and Manufacturing Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Cell Therapy Development and Manufacturing Services Key Company Head Office and Area Served Table 20. Global Cell Therapy Development and Manufacturing Services Company, Product Type & Application Table 21. Global Cell Therapy Development and Manufacturing Services Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Cell Therapy Development and Manufacturing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Cell Therapy Development and Manufacturing Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Type (2021-2026) Table 28. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Type (2027-2032) Table 29. Global Cell Therapy Development and Manufacturing Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Application (2021-2026) Table 33. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Application (2027-2032) Table 34. AGC Biologics Company Information Table 35. AGC Biologics Business Overview Table 36. AGC Biologics Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. AGC Biologics Cell Therapy Development and Manufacturing Services Product Portfolio Table 38. AGC Biologics Recent Development Table 39. AmplifyBio Company Information Table 40. AmplifyBio Business Overview Table 41. AmplifyBio Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. AmplifyBio Cell Therapy Development and Manufacturing Services Product Portfolio Table 43. AmplifyBio Recent Development Table 44. Charles River Laboratories Company Information Table 45. Charles River Laboratories Business Overview Table 46. Charles River Laboratories Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Charles River Laboratories Cell Therapy Development and Manufacturing Services Product Portfolio Table 48. Charles River Laboratories Recent Development Table 49. Thermo Fisher Scientific Company Information Table 50. Thermo Fisher Scientific Business Overview Table 51. Thermo Fisher Scientific Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Thermo Fisher Scientific Cell Therapy Development and Manufacturing Services Product Portfolio Table 53. Thermo Fisher Scientific Recent Development Table 54. FUJIFILM Cellular Dynamics Company Information Table 55. FUJIFILM Cellular Dynamics Business Overview Table 56. FUJIFILM Cellular Dynamics Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. FUJIFILM Cellular Dynamics Cell Therapy Development and Manufacturing Services Product Portfolio Table 58. FUJIFILM Cellular Dynamics Recent Development Table 59. Wuxi AppTec Company Information Table 60. Wuxi AppTec Business Overview Table 61. Wuxi AppTec Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Wuxi AppTec Cell Therapy Development and Manufacturing Services Product Portfolio Table 63. Wuxi AppTec Recent Development Table 64. KBI Biopharma Company Information Table 65. KBI Biopharma Business Overview Table 66. KBI Biopharma Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. KBI Biopharma Cell Therapy Development and Manufacturing Services Product Portfolio Table 68. KBI Biopharma Recent Development Table 69. Lonza Company Information Table 70. Lonza Business Overview Table 71. Lonza Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Lonza Cell Therapy Development and Manufacturing Services Product Portfolio Table 73. Lonza Recent Development Table 74. Catalent Biologics Company Information Table 75. Catalent Biologics Business Overview Table 76. Catalent Biologics Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Catalent Biologics Cell Therapy Development and Manufacturing Services Product Portfolio Table 78. Catalent Biologics Recent Development Table 79. Oxford BioMedica Company Information Table 80. Oxford BioMedica Business Overview Table 81. Oxford BioMedica Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Oxford BioMedica Cell Therapy Development and Manufacturing Services Product Portfolio Table 83. Oxford BioMedica Recent Development Table 84. GenScript Company Information Table 85. GenScript Business Overview Table 86. GenScript Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. GenScript Cell Therapy Development and Manufacturing Services Product Portfolio Table 88. GenScript Recent Development Table 89. Cell-Easy Company Information Table 90. Cell-Easy Business Overview Table 91. Cell-Easy Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Cell-Easy Cell Therapy Development and Manufacturing Services Product Portfolio Table 93. Cell-Easy Recent Development Table 94. SK pharmteco Company Information Table 95. SK pharmteco Business Overview Table 96. SK pharmteco Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. SK pharmteco Cell Therapy Development and Manufacturing Services Product Portfolio Table 98. SK pharmteco Recent Development Table 99. RoslinCT Company Information Table 100. RoslinCT Business Overview Table 101. RoslinCT Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. RoslinCT Cell Therapy Development and Manufacturing Services Product Portfolio Table 103. RoslinCT Recent Development Table 104. Cell and Gene Therapy Catapult Company Information Table 105. Cell and Gene Therapy Catapult Business Overview Table 106. Cell and Gene Therapy Catapult Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Cell and Gene Therapy Catapult Cell Therapy Development and Manufacturing Services Product Portfolio Table 108. Cell and Gene Therapy Catapult Recent Development Table 109. Cell Therapies Company Information Table 110. Cell Therapies Business Overview Table 111. Cell Therapies Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Cell Therapies Cell Therapy Development and Manufacturing Services Product Portfolio Table 113. Cell Therapies Recent Development Table 114. Minaris Regenerative Medicine Company Information Table 115. Minaris Regenerative Medicine Business Overview Table 116. Minaris Regenerative Medicine Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Minaris Regenerative Medicine Cell Therapy Development and Manufacturing Services Product Portfolio Table 118. Minaris Regenerative Medicine Recent Development Table 119. MEDINET Company Information Table 120. MEDINET Business Overview Table 121. MEDINET Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. MEDINET Cell Therapy Development and Manufacturing Services Product Portfolio Table 123. MEDINET Recent Development Table 124. North America Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026) & (US$ Million) Table 125. North America Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032) & (US$ Million) Table 126. North America Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026) & (US$ Million) Table 127. North America Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032) & (US$ Million) Table 128. North America Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) Table 130. North America Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) Table 131. Europe Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026) & (US$ Million) Table 132. Europe Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032) & (US$ Million) Table 133. Europe Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026) & (US$ Million) Table 134. Europe Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032) & (US$ Million) Table 135. Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) Table 137. Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) Table 138. China Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026) & (US$ Million) Table 139. China Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032) & (US$ Million) Table 140. China Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026) & (US$ Million) Table 141. China Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026) & (US$ Million) Table 143. Asia Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032) & (US$ Million) Table 144. Asia Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026) & (US$ Million) Table 145. Asia Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032) & (US$ Million) Table 146. Asia Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) Table 148. Asia Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) Table 149. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026) & (US$ Million) Table 150. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032) & (US$ Million) Table 151. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) Table 155. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Cell Therapy Development and Manufacturing Services Product Image Figure 2. Global Cell Therapy Development and Manufacturing Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cell Therapy Development and Manufacturing Services Market Share by Type: 2025 VS 2032 Figure 4. Stem Cell Therapy Image Figure 5. Somatic Cell Therapy Image Figure 6. Global Cell Therapy Development and Manufacturing Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Cell Therapy Development and Manufacturing Services Market Share by Application: 2025 VS 2032 Figure 8. Pharmaceutical Company Image Figure 9. Research Institute Image Figure 10. Global Cell Therapy Development and Manufacturing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 12. Global Cell Therapy Development and Manufacturing Services Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Cell Therapy Development and Manufacturing Services Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Cell Therapy Development and Manufacturing Services Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell Therapy Development and Manufacturing Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Type (2021-2032) Figure 19. Global Cell Therapy Development and Manufacturing Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Application (2021-2032) Figure 21. North America Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 22. North America Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032) Figure 23. North America Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032) Figure 24. North America Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032) Figure 25. United States Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 26. Canada Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 28. Europe Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 29. Europe Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032) Figure 30. Europe Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032) Figure 31. Europe Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032) Figure 32. Germany Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 33. France Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 35. Italy Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 36. Russia Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 38. China Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 39. China Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032) Figure 40. China Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032) Figure 41. Asia Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 42. Asia Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032) Figure 43. Asia Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032) Figure 44. Asia Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032) Figure 45. Japan Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 49. India Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 50. Australia Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032) Figure 55. Brazil Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 60. UAE Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 62. Chile Cell Therapy Development and Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell Therapy
  • Somatic Cell Therapy
Applications
  • Pharmaceutical Company
  • Research Institute
Companies covered
  • AGC Biologics
  • AmplifyBio
  • Charles River Laboratories
  • Thermo Fisher Scientific
  • FUJIFILM Cellular Dynamics
  • Wuxi AppTec
  • KBI Biopharma
  • Lonza
  • Catalent Biologics
  • Oxford BioMedica
  • GenScript
  • Cell-Easy
  • SK pharmteco
  • RoslinCT
  • Cell and Gene Therapy Catapult
  • Cell Therapies
  • Minaris Regenerative Medicine
  • MEDINET

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cell Therapy Development and Manufacturing Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Stem Cell Therapy
  5. 1.2.3 Somatic Cell Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Cell Therapy Development and Manufacturing Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Company
  9. 1.3.3 Research Institute
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Cell Therapy Development and Manufacturing Services Growth Trends by Region
  12. 1.5.1 Global Cell Therapy Development and Manufacturing Services Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Cell Therapy Development and Manufacturing Services Market Size by Region (2021-2026)
  14. 1.5.3 Cell Therapy Development and Manufacturing Services Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Cell Therapy Development and Manufacturing Services Market Dynamics
  1. 2.1 Cell Therapy Development and Manufacturing Services Industry Trends
  2. 2.2 Cell Therapy Development and Manufacturing Services Industry Drivers
  3. 2.3 Cell Therapy Development and Manufacturing Services Industry Opportunities and Challenges
  4. 2.4 Cell Therapy Development and Manufacturing Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cell Therapy Development and Manufacturing Services Revenue by Company (2021-2026)
  2. 3.2 Global Cell Therapy Development and Manufacturing Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cell Therapy Development and Manufacturing Services Key Company Head office and Area Served
  4. 3.4 Global Cell Therapy Development and Manufacturing Services Company, Product Type & Application
  5. 3.5 Global Cell Therapy Development and Manufacturing Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cell Therapy Development and Manufacturing Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cell Therapy Development and Manufacturing Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cell Therapy Development and Manufacturing Services Tier 1, Tier 2, and Tier 3
4 Cell Therapy Development and Manufacturing Services Market by Type
  1. 4.1 Global Cell Therapy Development and Manufacturing Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2032)
  3. 4.3 Global Cell Therapy Development and Manufacturing Services Market Size Share by Type (2021-2032)
5 Cell Therapy Development and Manufacturing Services Market by Application
  1. 5.1 Global Cell Therapy Development and Manufacturing Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2032)
  3. 5.3 Global Cell Therapy Development and Manufacturing Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AGC Biologics
  2. 6.1.1 AGC Biologics Company Information
  3. 6.1.2 AGC Biologics Business Overview
  4. 6.1.3 AGC Biologics Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AGC Biologics Cell Therapy Development and Manufacturing Services Product Portfolio
  6. 6.1.5 AGC Biologics Recent Developments
  7. 6.2 AmplifyBio
  8. 6.2.1 AmplifyBio Company Information
  9. 6.2.2 AmplifyBio Business Overview
  10. 6.2.3 AmplifyBio Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 AmplifyBio Cell Therapy Development and Manufacturing Services Product Portfolio
  12. 6.2.5 AmplifyBio Recent Developments
  13. 6.3 Charles River Laboratories
  14. 6.3.1 Charles River Laboratories Company Information
  15. 6.3.2 Charles River Laboratories Business Overview
  16. 6.3.3 Charles River Laboratories Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Charles River Laboratories Cell Therapy Development and Manufacturing Services Product Portfolio
  18. 6.3.5 Charles River Laboratories Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific Cell Therapy Development and Manufacturing Services Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 FUJIFILM Cellular Dynamics
  26. 6.5.1 FUJIFILM Cellular Dynamics Company Information
  27. 6.5.2 FUJIFILM Cellular Dynamics Business Overview
  28. 6.5.3 FUJIFILM Cellular Dynamics Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 FUJIFILM Cellular Dynamics Cell Therapy Development and Manufacturing Services Product Portfolio
  30. 6.5.5 FUJIFILM Cellular Dynamics Recent Developments
  31. 6.6 Wuxi AppTec
  32. 6.6.1 Wuxi AppTec Company Information
  33. 6.6.2 Wuxi AppTec Business Overview
  34. 6.6.3 Wuxi AppTec Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Wuxi AppTec Cell Therapy Development and Manufacturing Services Product Portfolio
  36. 6.6.5 Wuxi AppTec Recent Developments
  37. 6.7 KBI Biopharma
  38. 6.7.1 KBI Biopharma Company Information
  39. 6.7.2 KBI Biopharma Business Overview
  40. 6.7.3 KBI Biopharma Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 KBI Biopharma Cell Therapy Development and Manufacturing Services Product Portfolio
  42. 6.7.5 KBI Biopharma Recent Developments
  43. 6.8 Lonza
  44. 6.8.1 Lonza Company Information
  45. 6.8.2 Lonza Business Overview
  46. 6.8.3 Lonza Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Lonza Cell Therapy Development and Manufacturing Services Product Portfolio
  48. 6.8.5 Lonza Recent Developments
  49. 6.9 Catalent Biologics
  50. 6.9.1 Catalent Biologics Company Information
  51. 6.9.2 Catalent Biologics Business Overview
  52. 6.9.3 Catalent Biologics Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Catalent Biologics Cell Therapy Development and Manufacturing Services Product Portfolio
  54. 6.9.5 Catalent Biologics Recent Developments
  55. 6.10 Oxford BioMedica
  56. 6.10.1 Oxford BioMedica Company Information
  57. 6.10.2 Oxford BioMedica Business Overview
  58. 6.10.3 Oxford BioMedica Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Oxford BioMedica Cell Therapy Development and Manufacturing Services Product Portfolio
  60. 6.10.5 Oxford BioMedica Recent Developments
  61. 6.11 GenScript
  62. 6.11.1 GenScript Company Information
  63. 6.11.2 GenScript Business Overview
  64. 6.11.3 GenScript Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 GenScript Cell Therapy Development and Manufacturing Services Product Portfolio
  66. 6.11.5 GenScript Recent Developments
  67. 6.12 Cell-Easy
  68. 6.12.1 Cell-Easy Company Information
  69. 6.12.2 Cell-Easy Business Overview
  70. 6.12.3 Cell-Easy Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Cell-Easy Cell Therapy Development and Manufacturing Services Product Portfolio
  72. 6.12.5 Cell-Easy Recent Developments
  73. 6.13 SK pharmteco
  74. 6.13.1 SK pharmteco Company Information
  75. 6.13.2 SK pharmteco Business Overview
  76. 6.13.3 SK pharmteco Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 SK pharmteco Cell Therapy Development and Manufacturing Services Product Portfolio
  78. 6.13.5 SK pharmteco Recent Developments
  79. 6.14 RoslinCT
  80. 6.14.1 RoslinCT Company Information
  81. 6.14.2 RoslinCT Business Overview
  82. 6.14.3 RoslinCT Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 RoslinCT Cell Therapy Development and Manufacturing Services Product Portfolio
  84. 6.14.5 RoslinCT Recent Developments
  85. 6.15 Cell and Gene Therapy Catapult
  86. 6.15.1 Cell and Gene Therapy Catapult Company Information
  87. 6.15.2 Cell and Gene Therapy Catapult Business Overview
  88. 6.15.3 Cell and Gene Therapy Catapult Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Cell and Gene Therapy Catapult Cell Therapy Development and Manufacturing Services Product Portfolio
  90. 6.15.5 Cell and Gene Therapy Catapult Recent Developments
  91. 6.16 Cell Therapies
  92. 6.16.1 Cell Therapies Company Information
  93. 6.16.2 Cell Therapies Business Overview
  94. 6.16.3 Cell Therapies Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Cell Therapies Cell Therapy Development and Manufacturing Services Product Portfolio
  96. 6.16.5 Cell Therapies Recent Developments
  97. 6.17 Minaris Regenerative Medicine
  98. 6.17.1 Minaris Regenerative Medicine Company Information
  99. 6.17.2 Minaris Regenerative Medicine Business Overview
  100. 6.17.3 Minaris Regenerative Medicine Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Minaris Regenerative Medicine Cell Therapy Development and Manufacturing Services Product Portfolio
  102. 6.17.5 Minaris Regenerative Medicine Recent Developments
  103. 6.18 MEDINET
  104. 6.18.1 MEDINET Company Information
  105. 6.18.2 MEDINET Business Overview
  106. 6.18.3 MEDINET Cell Therapy Development and Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 MEDINET Cell Therapy Development and Manufacturing Services Product Portfolio
  108. 6.18.5 MEDINET Recent Developments
7 North America
  1. 7.1 North America Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
  2. 7.2 North America Cell Therapy Development and Manufacturing Services Market Size by Type
  3. 7.2.1 North America Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032)
  6. 7.3 North America Cell Therapy Development and Manufacturing Services Market Size by Application
  7. 7.3.1 North America Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032)
  10. 7.4 North America Cell Therapy Development and Manufacturing Services Market Size by Country
  11. 7.4.1 North America Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
  2. 8.2 Europe Cell Therapy Development and Manufacturing Services Market Size by Type
  3. 8.2.1 Europe Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032)
  6. 8.3 Europe Cell Therapy Development and Manufacturing Services Market Size by Application
  7. 8.3.1 Europe Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032)
  10. 8.4 Europe Cell Therapy Development and Manufacturing Services Market Size by Country
  11. 8.4.1 Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
  2. 9.2 China Cell Therapy Development and Manufacturing Services Market Size by Type
  3. 9.2.1 China Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026)
  4. 9.2.2 China Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032)
  5. 9.2.3 China Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032)
  6. 9.3 China Cell Therapy Development and Manufacturing Services Market Size by Application
  7. 9.3.1 China Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026)
  8. 9.3.2 China Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032)
  9. 9.3.3 China Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
  2. 10.2 Asia Cell Therapy Development and Manufacturing Services Market Size by Type
  3. 10.2.1 Asia Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032)
  6. 10.3 Asia Cell Therapy Development and Manufacturing Services Market Size by Application
  7. 10.3.1 Asia Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032)
  10. 10.4 Asia Cell Therapy Development and Manufacturing Services Market Size by Country
  11. 10.4.1 Asia Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst